Complete quality testing for pharmaceutical finished dosage forms from an NABL-accredited laboratory in India.
Pharmaceutical finished product testing is the final quality verification before a drug product reaches patients. Auriga Research provides NABL-accredited finished product testing services for all dosage forms — tablets, capsules, oral liquids, topicals, injectables, ophthalmics, and inhalation products. Our testing covers the complete pharmacopoeial specification including identity, assay, dissolution, content uniformity, related substances, microbial quality, and dosage-form-specific parameters.
For solid oral dosage forms, our testing includes hardness, friability, disintegration, dissolution profiling (USP apparatus I and II), uniformity of dosage units, and stability-indicating assay and impurity methods. For parenteral products, we perform sterility testing, bacterial endotoxin testing, particulate matter, pH, osmolality, and container closure integrity assessments. Topical products are evaluated for content uniformity, pH, viscosity, and in vitro release testing.
We support both one-time product testing and ongoing batch release programmes with scheduled turnaround commitments. All reports include certificate of analysis with raw data traceability, pharmacopoeial compliance statements, and electronic delivery for seamless integration with your quality management system.
NABL-accredited testing for all dosage forms with 7-10 day turnaround. Batch release programmes and certificate of analysis generation.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing